PUBLISHER: TechSci Research | PRODUCT CODE: 1255234
PUBLISHER: TechSci Research | PRODUCT CODE: 1255234
Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Gene Type, By Product Type, By Technique, By Application, By End User, By Region and Competition
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Cloning & Mutagenesis Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing cloning approaches in different genetic applications like reproductive cloning and genetic cloning. Additionally, various new product launches in the cloning and mutagenesis market, which will demand cloning and mutagenesis kits, along with government organizations investing in stem cell research for the development of new treatments and therapy, have significantly increased the demand for cloning and mutagenesis across different parts of the globe. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cloning and mutagenesis, thereby fuelling market growth through 2028. Besides, growing awareness about the advantages of using gene therapy and diagnosis, along with increasing healthcare expenditure on chronic disease treatment across the globe, are further expected to support the cloning and mutagenesis market during the forecast period. In 2022, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.
Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fueling the Market Growth
Increasing research and development regarding cloning and mutagenesis for the development of cancer therapies and other rare disorders is expected to create lucrative growth in the market during the forecast period. Government organizations are focusing on developed infrastructure with higher profits. Different types of innovative and ethically accepted therapies available for cancer therapy, along with the increasing development of new products, are expected to boost market growth over the years. In May 2020, Takara Bio announced a collaboration with AGC Biologics, and their businesses would collaborate on a prophylactic DNA vaccine against COVID-19 with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine. . as public-funded research is getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development. In 2020, an estimated 276,480 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,530 new cases of non-invasive (in situ) breast cancer. The increasing cloning of genes for the synthesis of antibiotics, hormones, and vitamins, among others, for the treatment of issues such as cystic fibrosis is propelling the market growth.
Increasing Investment by Government Organizations is Driving the Market Growth
Important factors which are expected to create lucrative growth in the market include a favorable funding scenario for gene synthesis and cloning services, along with technological advancement in the treatment, followed by research, subcloning services, and rising synergistic activities in the market. Increasing demand for gene therapy and growing adoption of novel and advanced DNA cloning technologies are expected to create a lucrative growth of the market during the forecast period.
Market Segmentation
Global cloning & mutagenesis market can be segmented by gene type, product type, technique, application, end-user, and by region. Based on gene type, the market can be divided into Standard and Complex. Based on product type, the market can be divided into Cloning Kits and Mutagenesis Kits. Based on technique, the market can be segmented into Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, and Others. Based on application, the market can be segmented into Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, and Others. Based on the end user, the market can be differentiated into Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America.
Market Players
Agilent Technologies, Inc., Eurofins Scientific SE, Sartorius AG, Collecta, Inc., Codex DNA Inc., Lonza Group AG, Charles River Laboratories International, Inc., TransGene Biotech Co. Ltd., Takara Bio, Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Cloning & Mutagenesis Market.
Recent Developments
- In Jan 2021, Codex DNA and Pfizer signed an early access collaboration and licensing agreement, which will allow Pfizer to use CodexDNA's novel enzymatic DNA synthesis technology in its research and development of mRNA-based vaccines and biotherapies and it will be responsible for further developing the technology.
- In May 2020, GenScript just launched a GMP single-strand and double-strand DNA service to aid in the growth of gene and cell therapies. The announcement highlights GenScript's commitment to assisting entire non-viral cell therapy development through the IND-enabling and clinical stages.
Report Scope
In this report, global cloning & mutagenesis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Cloning & Mutagenesis Market, By Gene Type:
- Standard
- Complex
Cloning & Mutagenesis Market, By Product Type:
- Cloning Kits
- Mutagenesis Kits
Cloning & Mutagenesis Market, By Technique:
- Topo PCR Cloning
- Blunt End Cloning
- Seamless Cloning
- Site-Directed Mutagenesis
- Others
Cloning & Mutagenesis Market, By Application:
- Gene Synthesis
- Gene Expression
- Gene Therapy
- Vaccine Research
- Others
Cloning & Mutagenesis Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Others
Cloning & Mutagenesis Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Cloning & Mutagenesis Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cloning & Mutagenesis Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Gene Type (Standard v/s Complex)
- 5.2.2. By Product Type (Cloning Kits v/s Mutagenesis Kits)
- 5.2.3. By Technique (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others)
- 5.2.4. By Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, Others)
- 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2022)
- 5.3. Market Map
- 5.3.1. By Gene Type
- 5.3.2. By Product Type
- 5.3.3. By Technique
- 5.3.4. By Application
- 5.3.5. By End User
- 5.3.6. By Region
6. North America Cloning & Mutagenesis Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Gene Type
- 6.2.2. By Product Type
- 6.2.3. By Technique
- 6.2.4. By Application
- 6.2.5. By End User
- 6.2.6. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Cloning & Mutagenesis Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Gene Type
- 6.3.1.2.2. By Product Type
- 6.3.1.2.3. By Technique
- 6.3.1.2.4. By Application
- 6.3.1.2.5. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Cloning & Mutagenesis Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Gene Type
- 6.3.2.2.2. By Product Type
- 6.3.2.2.3. By Technique
- 6.3.2.2.4. By Application
- 6.3.2.2.5. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Cloning & Mutagenesis Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Gene Type
- 6.3.3.2.2. By Product Type
- 6.3.3.2.3. By Technique
- 6.3.3.2.4. By Application
- 6.3.3.2.5. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Cloning & Mutagenesis Market Outlook
7. Europe Cloning & Mutagenesis Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Gene Type
- 7.2.2. By Product Type
- 7.2.3. By Technique
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Cloning & Mutagenesis Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Gene Type
- 7.3.1.2.2. By Product Type
- 7.3.1.2.3. By Technique
- 7.3.1.2.4. By Application
- 7.3.1.2.5. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Cloning & Mutagenesis Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Gene Type
- 7.3.2.2.2. By Product Type
- 7.3.2.2.3. By Technique
- 7.3.2.2.4. By Application
- 7.3.2.2.5. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Cloning & Mutagenesis Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Gene Type
- 7.3.3.2.2. By Product Type
- 7.3.3.2.3. By Technique
- 7.3.3.2.4. By Application
- 7.3.3.2.5. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Cloning & Mutagenesis Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Gene Type
- 7.3.4.2.2. By Product Type
- 7.3.4.2.3. By Technique
- 7.3.4.2.4. By Application
- 7.3.4.2.5. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Cloning & Mutagenesis Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Gene Type
- 7.3.5.2.2. By Product Type
- 7.3.5.2.3. By Technique
- 7.3.5.2.4. By Application
- 7.3.5.2.5. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. France Cloning & Mutagenesis Market Outlook
8. Asia-Pacific Cloning & Mutagenesis Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Gene Type
- 8.2.2. By Product Type
- 8.2.3. By Technique
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cloning & Mutagenesis Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Gene Type
- 8.3.1.2.2. By Product Type
- 8.3.1.2.3. By Technique
- 8.3.1.2.4. By Application
- 8.3.1.2.5. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Cloning & Mutagenesis Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Gene Type
- 8.3.2.2.2. By Product Type
- 8.3.2.2.3. By Technique
- 8.3.2.2.4. By Application
- 8.3.2.2.5. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Cloning & Mutagenesis Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Gene Type
- 8.3.3.2.2. By Product Type
- 8.3.3.2.3. By Technique
- 8.3.3.2.4. By Application
- 8.3.3.2.5. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Cloning & Mutagenesis Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Gene Type
- 8.3.4.2.2. By Product Type
- 8.3.4.2.3. By Technique
- 8.3.4.2.4. By Application
- 8.3.4.2.5. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Cloning & Mutagenesis Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Gene Type
- 8.3.5.2.2. By Product Type
- 8.3.5.2.3. By Technique
- 8.3.5.2.4. By Application
- 8.3.5.2.5. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Cloning & Mutagenesis Market Outlook
9. South America Cloning & Mutagenesis Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Gene Type
- 9.2.2. By Product Type
- 9.2.3. By Technique
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Cloning & Mutagenesis Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Gene Type
- 9.3.1.2.2. By Product Type
- 9.3.1.2.3. By Technique
- 9.3.1.2.4. By Application
- 9.3.1.2.5. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Cloning & Mutagenesis Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Gene Type
- 9.3.2.2.2. By Product Type
- 9.3.2.2.3. By Technique
- 9.3.2.2.4. By Application
- 9.3.2.2.5. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Cloning & Mutagenesis Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Gene Type
- 9.3.3.2.2. By Product Type
- 9.3.3.2.3. By Technique
- 9.3.3.2.4. By Application
- 9.3.3.2.5. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Cloning & Mutagenesis Market Outlook
10. Middle East and Africa Cloning & Mutagenesis Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Gene Type
- 10.2.2. By Product Type
- 10.2.3. By Technique
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Cloning & Mutagenesis Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Gene Type
- 10.3.1.2.2. By Product Type
- 10.3.1.2.3. By Technique
- 10.3.1.2.4. By Application
- 10.3.1.2.5. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Cloning & Mutagenesis Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Gene Type
- 10.3.2.2.2. By Product Type
- 10.3.2.2.3. By Technique
- 10.3.2.2.4. By Application
- 10.3.2.2.5. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Cloning & Mutagenesis Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Gene Type
- 10.3.3.2.2. By Product Type
- 10.3.3.2.3. By Technique
- 10.3.3.2.4. By Application
- 10.3.3.2.5. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Cloning & Mutagenesis Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Competitive Landscape
- 13.1. Business Overview
- 13.2. Product Offerings
- 13.3. Recent Developments
- 13.4. Financials (As Reported)
- 13.5. Key Personnel
- 13.6. SWOT Analysis
- 13.6.1. Agilent Technologies, Inc.
- 13.6.2. Eurofins Scientific SE
- 13.6.3. Sartorius AG
- 13.6.4. Collecta, Inc.
- 13.6.5. Codex DNA Inc.
- 13.6.6. Lonza Group AG
- 13.6.7. Charles River Laboratories International, Inc.
- 13.6.8. TransGene Biotech Co. Ltd.
- 13.6.9. Takara Bio, Inc.
- 13.6.10. Thermo Fisher Scientific Inc.
14. Strategic Recommendations
